Search
Search Results
##search.searchResults.foundPlural##
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
5278PDF: 3051HTML: 2390 -
TYROSINE KINASE INHIBITORS AND INTERFERON
3074PDF: 1556HTML: 3107Cover Letter: 293 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1869PDF: 896HTML: 939jdoe, table 2 infections CML .doc: 266jdoe, table 1 infections CML .doc: 241 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3945PDF: 1838HTML: 2786 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3600PDF: 1724HTML: 4105 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2468PDF: 1151HTML: 2046Characteristic of study group: 289 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277976PDF: 1929HTML: 3921 -
ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
3109PDF: 1376HTML: 2857Figure 1: 243 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3395PDF: 1475HTML: 4172 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2421PDF: 1731HTML: 778 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4267PDF: 1686HTML: 9336Untitled: 368Untitled: 241Untitled: 230Untitled: 248Untitled: 241Untitled: 411 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1678PDF: 1364HTML: 549 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
992PDF: 589HTML: 264Suppl. Files: 370 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
3048PDF: 1232HTML: 3098 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1510PDF: 960HTML: 5104INSTITUTE PUBLICATION COMMITTEE APPROVAL: 234 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4533PDF: 2073HTML: 5581Table 1: 331 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3517PDF: 1662HTML: 588 -
How I treat acute and persistent sickle cell pain
2197PDF: 1218HTML: 824 -
DNA Repair Genes and Chronic Myeloid Leukemia: XPD (751), XRCC1 (399), XRCC4-Intron 3, XRCC4 (1394) Gene Polymorphisms Polymorphisms of DNA Repair Genes in CML
1322PDF: 540HTML: 301 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1823PDF: 1184HTML: 532 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1260PDF: 1338HTML: 151 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1964PDF: 1287HTML: 384 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
3071PDF: 778HTML: 1980figure 1: 258figure 2: 237 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
657PDF: 329HTML: 169 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
2006PDF: 741HTML: 384 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2220PDF: 195HTML: 54 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1502PDF: 1162HTML: 498 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1676PDF: 1007HTML: 2019Figure: 241Tables: 247ALL revision 1: 378response to reviewer: 255 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
2252HTML: 1791PDF: 1244
1 - 48 of 48 items







